The Roundup – February 15, 2024

View this email in your browser
February 15, 2024
Member News

More Industry News

Welcome The National Organization for Rare Disorders (NORD)The National Organization for Rare Disorders (NORD) is a 501(c)(3) patient advocacy organization that improves the health and well-being of patients living with rare diseases by improving care, accelerating research, and driving public policy. Their Corporate Council comprises over a hundred biopharmaceutical companies, clinical research organizations, and other stakeholders involved in the drug development process for orphan treatments. NORD’s membership includes more than 340 patient advocacy organizations and 40+ Rare Disease Centers of Excellence, including Yale New Haven Hospital.Learn more
BioCTEdge Partner HighlightBioCTEdge partner Crown Uniform & Linen Service helps meet the needs of BioCT members with top-tier medical apparel and linens. BioCT members can access exclusive savings of 30% – 50% on a comprehensive range of apparel and linen service programs, with many personalized options available. Discover more about this partnership and explore our offerings here.
With Connecticut’s legislative session starting a week ago, we have our “policy leads” Chris Smith and John Harkins of Rome, Smith, Lutz, & Kowalski on the ground sending every relevant bill back to our tremendous Government Affairs Committee for comments. We are on standby for any bills requiring in-person testimony.

There is also a flurry of activity on the federal level. Here is an update from BIO:

Biopharma CEOs at Senate HELPLast Thursday, the Senate HELP Committee held a hearing entitled, “Why Does the United States Pay, by Far, the Highest Prices in the World for Prescription Drugs?” See Good Day BIO for remarks from biopharma CEOs and Ranking Member Bill Cassidy, M.D. (R-LA).

BIO Member Talks IP on the HillLast Wednesday, BIO Board member, Eddie J. Sullivan, co-founder and President of SAB Biotherapeutics testified before the House Committee on Ways and Means Subcommittee on Trade during a hearing titled “Advancing America’s Interests at the World Trade Organization’s 13th Ministerial Meeting.” Sullivan stated the proposal to waive WTO protection of IP for COVID-19 therapeutics and diagnostics would not only negatively impact startups like his company, but the entire biotech industry. – See Good Day BIO for a recap.

Artificial Intelligence in HealthcareThe Senate Finance Committee held a hearing titled, “Artificial Intelligence and Health Care: Promise and Pitfalls.” Chairman Wyden addressed concerns of equality in AI healthcare algorithms. The overall sentiment being, while artificial intelligence has potential to advance healthcare, there needs to be a legislative framework to protect patient privacy without stifling innovation.


  • BIO’s Comments to NIST on March-In RFI: BIO submitted comments to NIST on the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights.
  • House Oversight & Accountability Committee Advances PBM Legislation: H.R 6283, the Delinking Revenue from Unfair Gouging (DRUG) Act, was approved by 20-11 during the House Oversight Committee mark-up.
  • House Budget Committee Passes Preventative Care Legislation: The House Budget Committee unanimously approved H.R. 766, the Preventative Health Savings Act.
  • FDA Modernization Act 3.0 Introduced In The HouseFDA Modernization Act 3.0 was introduced by Reps. Buddy Carter (R-GA), Nanette Barragán (D-CA), Diana Harshbarger (R-TN), and Vern Buchanan (R-FL).

More News:

  • FTC March-In Comments to NIST: Today, the Federal Trade Commission (FTC) submitted their comments to the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights. – The Bayh-Dole Act is intended to enable innovation, and the “march-in” rights clause cannot be used for price controls, BIO explains in comments to the Biden administration.
  • CBO Releases Budget and Economic Outlook 2024 to 2034: This week, CBO released The Budget and Economic Outlook: 2024 to 2034. See their Report and Statement.
— Jodie GillonPresident and CEO
BioCT member HAVEN Human Asset Ventures is now enrolling participants in their Leadership Foundations Program.HAVEN specializes in leadership development for biotech companies. The program gives leaders at all levels the foundational skills for leading self and others. Since the first cohort began in 2019, more than 300 leaders have graduated from the program.

Some of the Benefits of HAVEN’s Leadership Foundations Program

  • Flexibility.  Leadership Foundations has been designed with a variety of learning modalities: faculty led workshops that drive new insights and application, along with asynchronous peer learning and online learning. Its virtual delivery model allows HAVEN to meet leaders where they are, anywhere in the world.
  • Just-in-time.  Not all clients are ready for an in-house programs but have a few leaders who need development. Or, they have new hires or newly promoted leaders who need to get ramped up on a set of leadership practices complimentary to their current culture of management.  Leadership Foundations is offered 2-4 times a year.
  • Try it out. Considering bringing leadership development inside? Leadership Foundations is a great opportunity to try out programs with a few leaders for minimal investment to see if HAVEN is the right fit.
  • Safe Space. Some clients send a few leaders to the program who would like a development experience outside of their in–house programs.

PROGRAM START DATE: March 7thFor more details: see click here and email 

Save the Date – Artificial Intelligence in HealthcareMarch 16th, 8 – 12 PM
GNHCC Regional Workforce Summit TODAY February 15, 3:00 – 6:00 pmThe summit will focus on strategies to retain and attract talent to our region. We’re partnering with our local colleges and universities to engage students and businesses for networking…Collaborative Connecticut TODAY February 15, 5:00 – 7:00 pmJoin us at Da Legna at Nolo for a cash bar, tasty pizza sponsored by ZehnTek, and networking!Small Business Council & PULSE Luncheon – Hosted by GNHCC Wednesday, February 21, 12:00 – 2:00 pmParticipate in Wooster Square Advisors’ dynamic financial literacy presentation and acquire vital insights for effective money management. Discover practical tips covering budgeting, saving…BIO CEO & Investor Conference Monday, February 26 – Tuesday, February 27Don’t miss one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of…Navigating Credits and Incentives: ERC, WOTC, and More – Hosted by CLA Thursday, February 29, 12:00 – 1:00 pmAttend our complimentary webinar as CLA tax professionals show you how to navigate the complex landscape of employment-related tax credits. We’ll cover the employee retention credit… Connecticut Science Center – Pathways to Stem NightThursday, February 29, 5:00 – 8:00 pmManufacturing careers are in high demand, and increasing access to education and training opportunities is one of the first steps toward fortifying Connecticut’s workforce pipeline. With that…Register Now!

Rare Disease Day Forum Thursday, March 7, 1:30 – 4:30 pmJoin us for an afternoon of industry-led discussions on innovation in rare disease diagnostics and treatments, along with the promising impact of these advancements on patient outcomes.CURE Rare Disease Lab Grand Opening Saturday March 16, 11:00 am – 2:00 pmThis event promises a unique opportunity to witness the ribbon-cutting ceremony, explore the facility, and enjoy a lunch. Make sure to mark your calendar for this special occasion…2024 BIO International Convention Monday, June 3 – Thursday, June 6The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the…

Full Events Calendar
Please email Caitlin Truesdale to share any news and events: